Die Arzneimitteltherapie bei Frauen im gebärfähigen Alter ist jedoch schlecht dokumentiert.
Das geht aus unseren Umfrageergebnissen hervor. Nur wenige Frauen, die bereits vor ihrer …

Less than 10% of medicines approved by the FDA since 1980 have provided enough
information as regards risks for birth defects associated with their use (Adam et al.(2011)[1]) …

Sicher dosieren in der Schwangerschaft Der Schutz von ungeborenen Leben ist ein hohes
Gut, welches auf keinen Fall gefährdet werden soll. Und doch kommt es vor, dass …

Since pregnant and lactating women have historically been excluded from drug
development trials, safety studies need to be conducted postapproval. This study evaluated …

Choosing appropriate medication doses for pregnant women is a difficult balancing act, as
the mother's need for treatment must be weighed against the risk of fetal harm. The latter is …

Nearly every pregnant woman has faced a decision about whether or not to take a
medication during pregnancy, ranging from over-the-counter antacids for gastroesophageal …

Introduction Maternal demographics have evolved, and more women than ever enter
pregnancy with preexisting comorbidity and with potentially complex medication exposure …

Is the European Union (EU) regulatory framework concerning pregnant women and women
at risk of becoming pregnant fit for the purpose? This article discusses improvements in how …

Purpose To explore trends in use of maternal medication 3 months prior to, during and 3
months after pregnancy. Methods Data on births from the Medical Birth Registry of Norway …

Objective: To provide guidance for clinicians on risk assessment of medication use during
pregnancy and lactation. Data Sources: Authors completed PubMed searches to identify …